1. Establish what is being priced
An FDA submission identifies a regulatory record, not a commercial bundle. Anchor the offer to the exact proposed product, version, modules, geography, term and currency. The FDA source below supports record interpretation, not the cost questions or a price benchmark.
- Is pricing per examination, site, scanner, reader, concurrent user or contract term? What minimums, volume bands and overage rules apply?
- Which licensed functions, supported inputs and integrations are included, and which require separate products or agreements?
- When does the offer expire, who supplied it, and what source document will purchasing retain?
Source context: FDA list of artificial intelligence enabled medical devices
2. Account for the full ownership period
These are editorial planning prompts. Keep each unresolved cost explicit rather than treating an empty line as zero. Separate one-time costs from recurring costs and document any conversion into an annual amount.
- Have you accounted for license, implementation, interfaces, compute or hardware, support, training and internal staff time?
- What are the renewal, escalation, upgrade, migration, storage, data export, termination and exit obligations? Who pays when an adjacent system changes?
- Is each cost known, included, unknown or documented as not applicable? Retain the explanation and keep patient charges or reimbursement separate from procurement price.
Source context: FDA list of artificial intelligence enabled medical devices
3. Model benefits only after identifying a mechanism
A scenario is a set of your assumptions, not reported product evidence. The directory model covers one interpretation workflow. Released minutes represent potential capacity; cash benefit needs a documented mechanism. Net return and ROI require complete costs and benefit inputs. Capacity-only cases establish no cash benefit or ROI.
- What eligible volume, adoption, time change and realization assumptions will you test, and what source or facility estimate supports each one?
- Would the proposed change reduce an actual expense or enable staffed, demanded activity? Keep the same released time from being counted twice.
- What happens in low, base and high cases? Record unresolved costs and assumptions beside the result before attaching it to a committee packet.
Source context: FDA list of artificial intelligence enabled medical devices
Take the next step
Choose exact records, then open their checklist to prepare private supplier quote worksheets.
Explore a private interpretation-capacity and cost scenario · Read a fictional committee packet · Check system compatibility scope
The worksheets and scenario use your assumptions. Save or attach private inputs explicitly; public evidence does not turn those inputs into verified results. The public sample uses fictional facility values.
Sources and scope
Sources anchor the stated regulatory or interoperability context. The questions are original editorial prompts; a citation does not validate a financial assumption or establish local fit. Source dates below apply to this guide, not the whole directory.
- FDA list of artificial intelligence enabled medical devices
About this list and public decision summaries. Checked .
Regulatory record context only. Cost questions and model guidance are original editorial prompts; this source supports no price, reimbursement, saving or ROI claim.
Dataset and maintenance dates · Methods · Submit a source-backed correction